Publications by authors named "D Kling"

Claim this Profile
E
Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease.
Michael H Davidson, Michael Szarek, Philip Scheltens, Everard Vijverberg, Andrew Hsieh, Douglas Kling

J Prev Alzheimers Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative assessment of SNP genotyping assays for challenging forensic samples utilizing ancient DNA methods.
Adam Staadig, Maja Krzewińska, Maja Sidstedt, Daniel Kling, Siri Aili Fagerholm

Genome Biol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Obicetrapib Across the Spectrum of Background Lipid-Lowering Therapies: Pooled Analyses of the BROADWAY and BROOKLYN Randomized Trials.
Fotios Barkas, Michael Szarek, Adam J Nelson, Marc Ditmarsch, Douglas Kling

Eur J Prev Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Der neue Phosphodiesterasehemmer Enoximone: Einsatzmöglichkeiten im Rahmen herzchirurgischer Eingriffe.
J Boldt, D Kling, E Schuhmann, H H Scheld, G Hempelmann

Herz· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Kolloidosmotischer Druck und extravaskuläres Lungenwasser nach extrakorporaler Zirkulation.
J Boldt, B von Bormann, D Kling, U Börner, J Mulch

Herz· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis